Human Breast Cancer Organoid
Please note: All purchases should be limited to United States.
For complete Terms and Conditions, please click here.
Early detection and treatment are crucial in the survival rate of breast cancer patients. This necessitates the use of clinically relevant tumor models to understand the mechanism, analyze tumor biomarkers, and screen anticancer drugs. 3D Ready™ Breast Cancer Organoids provide the platform to study tumor physiology and response to targeted therapies.
Part Number | Product Description | Source | Pathology | ER/PR/Her2 Immuno histochemistry Staining | Number of Organoids per Vial | Price (USD) |
---|---|---|---|---|---|---|
OES-BCO005-CXP1 | 3D Ready™ Breast Cancer Organoid, BCO-005 | Primary | Invasive Carcinoma Mixed | ER+/PR+/Her2- | 250,000 | 4,975 |
OES-BCO037-CXP1 | 3D Ready™ Breast Cancer Organoid, BCO-037 | PDX | Invasive Ductal Carcinoma | ER-/PR-/Her2- | 250,000 | 3,221 |
OES-BCO160-CXP1 | 3D Ready™ Breast Cancer Organoid, BCO-160 | PDX | Invasive Ductal Carcinoma/DCIS | ER+/PR-/Her2+ | 250,000 | 3,080 |
We Also Recommend